1. Department of Gene and Cell Medicine and Immunology Institute, Mount Sinai School of Medicine, New York, NY;
2. Institute for Vascular Medicine, Friedrich Schiller University of Jena, Jena, Germany;
3. Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;
4. Clinical Cooperation Group “Inflammatory Lung Diseases,” Asklepios-Fachklinik and Helmholtz Zentrum München, German Research Center for Environmental Health, Gauting, Germany;
5. Institute for Medical Microbiology, Immunology und Hygiene, Technische Universität München, München, Germany;
6. Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital Erlangen, Erlangen, Germany; and
7. Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom